Prescription of lipid-lowering medications for patients with type 2 diabetes mellitus and risk-associated LDL cholesterol: a nationwide study of guideline adherence from the Swedish National Diabetes Register

• Hoofdauteurs: Sofia Axia Karlsson (Auteur), Stefan Franzén (Auteur), Ann-Marie Svensson (Auteur), Mervete Miftaraj (Auteur), Björn Eliasson (Auteur), Karolina Andersson Sundell (Auteur)
• Formaat: Boek
• Gepubliceerd in: BMC, 2018-11-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Abstract Background Management of type 2 diabetes mellitus (T2DM) encompasses intensive glycaemic control, along with treatment of comorbidities and complications to handle the increased risk of cardiovascular disease (CVD). Improved control of LDL-cholesterol (LDL-C) with lipid-lowering medications...